Holen Sie sich die Stockscreener-App
26.79
0.04%
-0.01
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Patriot Financial Group Insurance Agency LLC Sells 90,653 Shares of Pfizer Inc. $PFE - MarketBeat
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $30.31 Million Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer’s CEO Just Bought $1 Million of Stock at $26. Here’s Where the Stock Could Go - TIKR.com
Pfizer Inc. $PFE Stock Position Lifted by Park National Corp OH - MarketBeat
Pfizer Inc. $PFE Holdings Lifted by QSM Asset Management Ltd - MarketBeat
Independent Financial Group LLC Purchases 57,994 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. • Robinhood Token Price, PFE Price, Live Charts, and Marketcap - Coinbase
Pfizer Inc. • Robinhood Token (PFE) Price, MarketCap, Charts and Fundamentals Info - BeInCrypto
New owner secures mystery tenant for Everett plant shelved by Pfizer - The Business Journals
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Carol Devine Miller sells stocks in Pfizer, Quest Diagnostics, Target, and U.S. Bancorp - Investing.com
Pfizer Veteran's Khartis Therapeutics Launches With $95 Million for Oral Thyroid Eye Disease Drug - finance.biggo.com
Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase - barrons.com
Breakthrough Properties Buys Biomanufacturing Campus in Everett, Secures Lease - MyNorthwest.com
Pfizer’s Korean Paxlovid Study Signals Ongoing Value in High‑Risk COVID Market - TipRanks
European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application - Benzinga
What Pfizer (PFE)'s EMA Lyme Vaccine Filing and Updated Outlook Means For Shareholders - simplywall.st
EMA Accepts Pfizer/Valneva’s Lyme Disease Vaccine Filing In Global First - insights.citeline.com
Recent Filing Shows That Rep. Carol Miller Sold Over $60K Worth of Pfizer Stock - Benzinga
EMA Begins Review of Pfizer-Valneva Lyme Disease Vaccine - Contract Pharma
QRG Capital Management Inc. Acquires 49,804 Shares of Pfizer Inc. $PFE - MarketBeat
PFE Stock Quote Price and Forecast - CNN
EMA validates Pfizer-Valneva Lyme disease vaccine application By Investing.com - Investing.com Canada
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - The Manila Times
Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money - Fast Company
Pfizer (NYSE:PFE) Trading 1.9% HigherWhat's Next? - MarketBeat
Pfizer (PFE) reports $170.4M across 20 institutional holdings in 13F - Stock Titan
Pfizer Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Pfizer Inc. (NYSE:PFE) Keeps Drawing Healthcare Focus? - kalkinemedia.com
Enterprise AI Profile: Pfizer's Federated AI Pipeline - Futuriom
Could Pfizer (NYSE:PFE) Draws Notice Amid Post-Pandemic Portfolio Shift Stay in Focus? - Kalkine Media
Why Is Pfizer (NYSE:PFE) Draws Dividend Focus as Inflation Data Calms Markets Worth Watching? - Kalkine Media
How Pfizer’s Higher 2026 Guidance And LITFULO Trial Results At Pfizer (PFE) Have Changed Its Investment Story - Yahoo Finance
Pfizer CEO Bourla Buys $1 Million in Shares as Drugmaker Fights Growth Doubts - finance.biggo.com
Pfizer stock steadies after Q2 2026 beat and modest guidance lift - AD HOC NEWS
Pfizer (NYSE:PFE) Guidance & Pipeline Put Valuation In Focus - kalkinemedia.com
Pfizer CEO Buys $1 Million of Stock - TradingView
Pfizer (PFE) Could Be 10% Undervalued Following Raised Revenue Guidance - simplywall.st
Pfizer, Inc. Stock 12‑Month Price Target Cut to $28.28, Implies 7% Upside - TradingView
China Surpasses US in Drug Trials as Washington RespondsPfizer (NYSE:PFE), Merck & Co (NYSE:MRK) - Benzinga
5 Insightful Analyst Questions From Pfizer’s Q2 Earnings Call - Yahoo Finance
Pfizer CEO Albert Bourla Acquires 38,000 Shares in August 2026 Open-Market Purchase - Kalkine Media
Pfizer (NYSE:PFE) Draws Value-Focused Attention As Pharma Steadies Amid Caution - Kalkine Media
Pfizer (NYSE:PFE) Shares Down 1.2%Time to Sell? - MarketBeat
Pfizer Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Pfizer Insider Bought Shares Worth $1,000,920, According to a Recent SEC Filing - marketscreener.com
Insulet hires Pfizer alum Joan Campion to lead external comms - Medical Marketing and Media
Listening to the Hemophilia Community: Pfizer Survey Reveals Unspoken Compromises - Pfizer
Why Is Pfizer (NYSE:PFE) Drawing Eyes as Markets Wait on Inflation Data? - Kalkine Media
Will Pfizer's Non-COVID Portfolio Drive Its Next Phase of Growth? - TradingView
Formation Bio taps Biogen, Pfizer alum to tackle R&D’s ‘boring middle’ - Pharma Voice
Erste Group Bank Increases Earnings Estimates for Pfizer - MarketBeat
Daiwa Securities Adjusts Price Target on Pfizer to $27 From $28, Maintains Neutral Rating - marketscreener.com
Pfizer (PFE) Agreed To A $44 Million Chantix Settlement - Yahoo Finance
Pfizer (PFE) Agrees To $44 Million Class Action Settlement - simplywall.st
Pfizer (NYSE:PFE) Shares Down 1.6%Here's What Happened - MarketBeat
Pfizer's Pipeline Could Change Everything (NYSE:PFE) - Seeking Alpha
Pfizer (NYSE: PFE): Acquisitions Reshape Its Healthcare Strategy - Kalkine Media
Pfizer Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock - The Globe and Mail
Pfizer agrees to $44M Chantix settlement. See if you qualify - Yahoo! Finance Canada
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026? - The Globe and Mail
Pfizer Sheds Former Warehouse Worker’s Disability Bias Claims - Bloomberg Law News
Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era? - Yahoo Finance
Pfizer Inc. $PFE Shares Bought by Handelsbanken Fonder AB - MarketBeat
KMG Fiduciary Partners LLC Acquires 39,875 Shares of Pfizer Inc. $PFE - MarketBeat
0.16%
1.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):